Last ¥6,820 JPY
Change Today -40.00 / -0.58%
Volume 108.8K
4967 On Other Exchanges
Symbol
Exchange
Munich
Tokyo
OTC US
As of 1:00 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

kobayashi pharmaceutical co (4967) Snapshot

Open
¥7,000
Previous Close
¥6,860
Day High
¥7,000
Day Low
¥6,810
52 Week High
12/15/14 - ¥7,340
52 Week Low
02/6/14 - ¥5,200
Market Cap
290.0B
Average Volume 10 Days
81.5K
EPS TTM
¥288.90
Shares Outstanding
42.5M
EX-Date
03/27/15
P/E TM
23.6x
Dividend
¥87.00
Dividend Yield
1.28%
Current Stock Chart for KOBAYASHI PHARMACEUTICAL CO (4967)

Related News

No related news articles were found.

kobayashi pharmaceutical co (4967) Related Businessweek News

No Related Businessweek News Found

kobayashi pharmaceutical co (4967) Details

Kobayashi Pharmaceutical Co., Ltd. manufactures and sells OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, sanitary products, and other products. The company operates through four segments: Consumer Products, Mail-Order, Medical Devices, and Other Business. The Consumer Products segment develops, produces, and sells OTC pharmaceuticals, oral hygiene products, and food products; and deodorizing air fresheners, sanitary products, household sundries, and body warmers. The Mail-Order segment sells nutritional supplements, skincare products, and similar items through telephone, Internet, and other channels. The Medical Devices segment sells medical equipment. The Other Business segment provides transportation, insurance agency, real estate management, and advertising planning and production services, as well as manufactures and distributes synthetic resin containers. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

2,364 Employees
Last Reported Date: 06/27/14
Founded in 1886

kobayashi pharmaceutical co (4967) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kobayashi pharmaceutical co (4967) Key Developments

Kobayashi Pharmaceutical Co. Ltd. to Report Q2, 2015 Results on Oct 30, 2014

Kobayashi Pharmaceutical Co. Ltd. announced that they will report Q2, 2015 results on Oct 30, 2014

Kobayashi Pharmaceutical Co. Ltd., Q2 2015 Earnings Call, Nov 05, 2014

Kobayashi Pharmaceutical Co. Ltd., Q2 2015 Earnings Call, Nov 05, 2014

Kobayashi Pharmaceutical Co. Ltd. Announces Earnings Results for the Year Ended March 31, 2014

Kobayashi Pharmaceutical Co. Ltd. announced earnings results for the year ended March 31, 2014. For the year, the company has reported that net income was JPY 12.31 billion, compared to JPY 12.18 billion for the year ended March 31, 2013. Net sales for the year ended March 31, 2014 were JPY 127.29 billion, compared to JPY 121.53 billion for the year ended March 31, 2013. Operating income for the year ended March 31, 2014 was JPY 18.12 billion, compared to JPY 16.9 billion for the year ended March 31, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4967:JP ¥6,820.00 JPY -40.00

4967 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4967.
View Industry Companies
 

Industry Analysis

4967

Industry Average

Valuation 4967 Industry Range
Price/Earnings 22.4x
Price/Sales 2.1x
Price/Book 2.1x
Price/Cash Flow 21.3x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOBAYASHI PHARMACEUTICAL CO, please visit www.kobayashi.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.